Abstract
Many questions about the natural history of both type 1 and type 2 diabetes remain unanswered, mostly because our present knowledge is derived from either in vitro studies or quite indirect in vivo measurements. Methods to noninvasively and repeatedly evaluate the mass and function of β-cells in vivo, two parameters that are central to the study of diabetes, are expected to change our understanding of this disease. However, and in spite of remarkable progress in many imaging techniques, no method yet fulfills the minimal requirements required for such an imaging, because of a combination of anatomical, biological, and technological problems. Here, we briefly review the major optical methods, which have been applied in imaging of the pancreatic β-cells, as well as the nonoptical methods, which may become relevant for the clinical assessment of islets, with particular attention to the individual advantages and limits of each approach.
Similar content being viewed by others
References
Antkowiak PF, Tersey SA, Carter JD, Vandsburger MH, Nadler JL, Epstein FH, Mirmira RG (2009) Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am J Physiol Endocrinol Metab 296:E573–E578
Antkowiak PF, Vandsburger MH, Epstein FH (2012) Quantitative pancreatic β cell MRI using manganese-enhanced Look-Locker imaging and two-site water exchange analysis. Magn Reson Med 67:1730–1739
Antkowiak PF, Stevens BK, Nunemaker CS et al (2013) Manganese-enhanced magnetic resonance imaging detects declining pancreatic beta-cell mass in a cyclophosphamide-accelerated mouse model of type 1 diabetes. Diabetes 62:44–48
Barnett BP, Ruiz-Cabello J, Hota P et al (2011) Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology 258:182–191
Barone B, Dantas JR, Almeida MH et al (2011) Pancreatic autoantibodies, HLA DR and PTPN22 polymorphisms in first degree relatives of patients with type 1 diabetes and multiethnic background. Exp Clin Endocrinol Diabetes 119:618–620
Behm CZ, Lindner JR (2006) Cellular and molecular imaging with targeted contrast ultrasound. Ultrasound Q 22:67–72
Berclaz C, Goulley J, Villiger M et al (2012) Diabetes imaging-quantitative assessment of islets of Langerhans distribution in murine pancreas using extended-focus optical coherence microscopy. Biomed Opt Express 3:1365–1380
Biancone L, Crich SG, Cantaluppi V, Romanazzi GM, Russo S, Scalabrino E, Esposito G, Figliolini F, Beltramo S, Perin PC, Segoloni GP, Aime S, Camussi G (2007) Magnetic resonance imaging of gadolinium-labeled pancreatic islets for experimental transplantation. NMR Biomed 20:40–48
Botsikas D, Terraz S, Vinet L et al (2012) Pancreatic magnetic resonance imaging after manganese injection distinguishes type 2 diabetic and normoglycemic patients. Islets 4:243–248
Bottazzo GF, Dean BM, McNally JM et al (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353–360
Bremer C, Bredow S, Mahmood U et al (2001) Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology 221:523–529
Bremer C, Ntziachristos V, Weitkamp B et al (2005) Optical imaging of spontaneous breast tumors using protease sensing ‘smart’ optical probes. Invest Radiol 40:321–327
Brom M, Oyen WJ, Joosten L, Gotthardt M, Boerman OC (2010) 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET. Eur J Nucl Med Mol Imaging 37:1345–1355
Danaei G, Finucane MM, Lu Y et al (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31–40
Danila D, Partha R, Elrod DB et al (2009) Antibody-labeled liposomes for CT imaging of atherosclerotic plaques: in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography. Tex Heart Inst J 36:393–403
Denis MC, Mahmood U, Benoist C et al (2004) Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci U S A 101:12634–12639
Eriksson AU, Svensson C, Hornblad A et al (2013) Near infrared optical projection tomography for assessments of beta-cell mass distribution in diabetes research. J Vis Exp 17:e50238
Falk GW (2009) Autofluorescence endoscopy. Gastrointest Endosc Clin N Am 19:209–220
Figueiredo JL, Alencar H, Weissleder R et al (2006) Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int J Cancer 118:2672–2677
Fu W, Wojtkiewicz G, Weissleder R et al (2012) Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging. Nat Immunol 13:361–368
Gaglia JL, Guimaraes AR, Harisinghani M et al (2011) Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest 121:442–445
Gimi B, Leoni L, Oberholzer J, Braun M, Avila J, Wang Y, Desai T, Philipson LH, Magin RL, Roman BB (2006) Functional MR microimaging of pancreatic beta-cell activation. Cell Transplant 15:195–203
Goland R, Freeby M, Parsey R et al (2009) 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med 50:382–389
Grossman EJ, Lee DD, Tao J et al (2010) Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice. PLoS One 5:e8749
Gupta H, Weissleder R (1996) Targeted contrast agents in MR imaging. Magn Reson Imaging Clin N Am 4:171–184
Hangiandreou NJ (2003) AAPM/RSNA physics tutorial for residents. Topics in US: B-mode US: basic concepts and new technology. Radiographics 23:1019–1033
Hara M, Dizon RF, Glick BS et al (2006) Imaging pancreatic beta-cells in the intact pancreas. Am J Physiol Endocrinol Metab 290:E1041–E1047
Harris PE, Farwell MD, Ichise M (2013) PET quantification of pancreatic VMAT 2 binding using (+) and (−) enantiomers of [(1)(8)F]FP-DTBZ in baboons. Nucl Med Biol 40:60–64
Hill ML, Corbin IR, Levitin RB et al (2010) In vitro assessment of poly-iodinated triglyceride reconstituted low-density lipoprotein: initial steps toward CT molecular imaging. Acad Radiol 17:1359–1365
Imagawa A, Hanafusa T, Tamura S et al (2001) Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 50:1269–1273
Jaffer FA, Weissleder R (2004) Seeing within: molecular imaging of the cardiovascular system. Circ Res 94:433–445
Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, Thielscher A, Kneilling M, Lichy MP, Eichner M, Klingel K, Reischl G, Widmaier S, Röcken M, Nutt RE, Machulla HJ, Uludag K, Cherry SR, Claussen CD, Pichler BJ (2008) Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 4:459–465
Kang NY, Lee SC, Park SJ et al (2013) Visualization and isolation of Langerhans islets by a fluorescent probe PiY. Angew Chem Int Ed Engl 52:8557–8560
Katsumata T, Oishi H, Sekiguchi Y et al (2013) Bioluminescence imaging of beta cells and intrahepatic insulin gene activity under normal and pathological conditions. PLoS One 8:e60411
Kircher MF, Willmann JK (2012) Molecular body imaging: MR imaging, CT, and US. Part I. Principles. Radiology 263:633–643
Klibanov AL, Rasche PT, Hughes MS et al (2004) Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles. Invest Radiol 39:187–195
Lamprianou S, Immonen R, Nabuurs C, Gjinovci A, Vinet L, Montet XC, Gruetter R, Meda P (2011) High-resolution magnetic resonance imaging quantitatively detects individual pancreatic islets. Diabetes 60:2853–2860
Lange N, Becker CD, Montet X (2008) Molecular imaging in a (pre-) clinical context. Acta Gastroenterol Belg 71:308–317
Lebastchi J, Herold KC (2012) Immunologic and metabolic biomarkers of beta-cell destruction in the diagnosis of type 1 diabetes. Cold Spring Harb Perspect Med 2:a007708
Leoni L, Roman BB (2010) MR imaging of pancreatic islets: tracking isolation, transplantation and function. Curr Pharm Des 16:1582–1594
Leoni L, Serai SD, Haque ME et al (2010) Functional MRI characterization of isolated human islet activation. NMR Biomed 23:1158–1165
Li J, Chaudhary A, Chmura SJ et al (2010) A novel functional CT contrast agent for molecular imaging of cancer. Phys Med Biol 55:4389–4397
Lin YJ, Koretsky AP (1997) Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med 38:378–388
Lin Y, Sun Z (2010) Current views on type 2 diabetes. J Endocrinol 204:1–11
Maahs DM, West NA, Lawrence JM et al (2010) Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 39:481–497
Marchetti P, Bugliani M, Boggi U et al (2012) The pancreatic beta cells in human type 2 diabetes. Adv Exp Med Biol 771:288–309
Mayo-Smith WW, Schima W, Saini S, Slater GJ, McFarland EG (1998) Pancreatic enhancement and pulse sequence analysis using low-dose mangafodipir trisodium. AJR Am J Roentgenol 170:649–652
Medarova Z, Castillo G, Dai G et al (2007) Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes. Diabetes 56:2677–2682
Monici M (2005) Cell and tissue autofluorescence research and diagnostic applications. Biotechnol Annu Rev 11:227–256
Montet X, Montet-Abou K, Reynolds F et al (2006a) Nanoparticle imaging of integrins on tumor cells. Neoplasia 8:214–222
Montet X, Weissleder R, Josephson L (2006b) Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. Bioconjug Chem 17:905–911
Montet-Abou K, Viallon M, Hyacinthe JN et al (2010) The role of imaging and molecular imaging in the early detection of metabolic and cardiovascular dysfunctions. Int J Obes (Lond) 34(Suppl 2):S67–S81
Moore A, Sun PZ, Cory D et al (2002) MRI of insulitis in autoimmune diabetes. Magn Reson Med 47:751–758
Moore A, Grimm J, Han B et al (2004) Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time. Diabetes 53:1459–1466
Normandin MD, Petersen KF, Ding YS et al (2012) In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using 18 F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 53:908–916
Ntziachristos V (2010) Going deeper than microscopy: the optical imaging frontier in biology. Nat Methods 7:603–614
Orban T, Sosenko JM, Cuthbertson D et al (2009) Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention trial-type 1. Diabetes Care 32:2269–2274
Pochon S, Tardy I, Bussat P et al (2010) BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 45:89–95
Rahier J, Guiot Y, Goebbels RM et al (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):32–42
Reiner T, Thurber G, Gaglia J et al (2011) Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog. Proc Natl Acad Sci USA 108:12815–12820
Reuveni T, Motiei M, Romman Z et al (2011) Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomedicine 6:2859–2864
Rorsman P, Berggren PO, Hellman B (1982) Manganese accumulation in pancreatic beta-cells and its stimulation by glucose. Biochem J 15:435–444
Selvaraju RK, Velikyan I, Johansson L, Wu Z, Todorov I, Shively J, Kandeel F, Korsgren O, Eriksson O (2013) In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-Exendin-4. J Nucl Med 8:1458–1463
Simpson NR, Souza F, Witkowski P et al (2006) Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nucl Med Biol 33:855–864
Singhal T, Ding YS, Weinzimmer D et al (2011) Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes. Mol Imaging Biol 13:973–984
Souza F, Simpson N, Raffo A et al (2006) Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J Clin Invest 116:1506–1513
Turvey SE, Swart E, Denis MC et al (2005) Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest 115:2454–2461
Vats D, Wang H, Esterhazy D et al (2012) Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia 55:2407–2416
Virostko J, Chen Z, Fowler M et al (2004) Factors influencing quantification of in vivo bioluminescence imaging: application to assessment of pancreatic islet transplants. Mol Imaging 3:333–342
Virostko J, Radhika A, Poffenberger G et al (2010) Bioluminescence imaging in mouse models quantifies beta cell mass in the pancreas and after islet transplantation. Mol Imaging Biol 12:42–53
Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A, Baldwin RM, Ansari MS, Hefti F, Skovronsky D, Kung HF, Herrera PL, Peterson TE, Meda P, Powers AC (2011) Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proc Natl Acad Sci U S A 108:20719–20724
Virostko J, Radhika A, Poffenberger G et al (2013) Bioluminescence imaging reveals dynamics of beta cell loss in the non-obese diabetic (NOD) mouse model. PLoS One 8:e57784
Wang RK (2002) Signal degradation by multiple scattering in optical coherence tomography of dense tissue: a Monte Carlo study towards optical clearing of biotissues. Phys Med Biol 47:2281–2299
Wang LV, Hu S (2012) Photoacoustic tomography: in vivo imaging from organelles to organs. Science 335:1458–1462
Weissleder R (2006) Molecular imaging in cancer. Science 312:1168–1171
Wild S, Roglic G, Green A et al (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
Willmann JK, Paulmurugan R, Chen K et al (2008) US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 246:508–518
Wu Z, Liu S, Hassink M, Nair I, Park R, Li L, Todorov I, Fox JM, Li Z, Shively JE, Conti PS, Kandeel F (2013) Development and evaluation of 18 F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets. J Nucl Med 54:244–251
Wyss C, Schaefer SC, Juillerat-Jeanneret L et al (2009) Molecular imaging by micro-CT: specific E-selectin imaging. Eur Radiol 19:2487–2494
Yin H, Park SY, Wang XJ et al (2013) Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin. PLoS One 8:e65777
Zhang Y, Chen W (2012) Radiolabeled glucagon-like peptide-1 analogues: a new pancreatic beta-cell imaging agent. Nucl Med Commun 33:223–227
Zhang B, Yang B, Zhai C et al (2013) The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI. Biomaterials 34:5843–5852
Acknowledgments
This work was supported by grants from the Swiss National Science Foundation (310000-109402, CR32I3_129987), the Juvenile Diabetes Research Foundation (40-2011-11, 99-2012-775), the European Union (BETAIMAGE 222980, IMIDIA 155055, BETATRAIN 289932), the Fondation Romande pour le Diabète, and the Boninchi Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Montet, X., Lamprianou, S., Vinet, L., Meda, P., Fort, A. (2014). Approaches for Imaging Pancreatic Islets: Recent Advances and Future Prospects. In: Islam, M. (eds) Islets of Langerhans, 2. ed.. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6884-0_39-2
Download citation
DOI: https://doi.org/10.1007/978-94-007-6884-0_39-2
Received:
Accepted:
Published:
Publisher Name: Springer, Dordrecht
Online ISBN: 978-94-007-6884-0
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences